SCHEMBL5398347

SCHEMBL5398347

CC[n+]1cc[nH]c1.F[B-](F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380245 0.91
Iodide SCHEMBL1842396 0.88
Bromide SCHEMBL6006268 0.88
Hydrochloric Acid SCHEMBL3900876 0.88
Chloromethane SCHEMBL9721446 0.86
Hydrochloric Acid SCHEMBL8067868 0.86
SCHEMBL4304047 0.83 FDPS (0.34) FDPS
SCHEMBL19975364 0.82 FDPS (0.36) FDPS
Perchlorate SCHEMBL6675047 0.82 FDPS (0.37) FDPS
SCHEMBL4420774 0.79 CHRM2 (0.35) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205699-B1 Solid state actuation using graphite intercalation compounds HRL LABORATORIES, LLC (US) 2007-04-17 US claimed
US-12486343-B2 Method for producing iodine-containing compound, and iodine-containing compound AGC Inc. (JP) 2025-12-02 US disclosed
WO-2023239643-A1 CURRENT COLLECTOR FOR LITHIUM BATTERY HONDA MOTOR CO., LTD. (JP) 2023-12-14 WO disclosed
US-20230203215-A1 METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND AGC Inc. (JP) 2023-06-29 US disclosed
EP-4094304-A1 PIEZOELECTRIC COMPOSITE MATERIALS HAVING IMPROVED PIEZOELECTRIC PROPERTIES COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2022-11-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203215-A1 METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND SSTR2, TPO, BRI3BP FDPS 3780/4885
US-12486343-B2 Method for producing iodine-containing compound, and iodine-containing compound SSTR2, TPO, BRI3BP FDPS 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.